The COVID-19 pandemic has taken a toll on all of us, but for people living with dementia and their families, the public health crisis…
Research has shown that glucose levels, the brain’s primary source of fuel, in the central nervous system diminishes in aging, and some researchers suggest that…
In Being Patient’s LiveTalk series, Dr. David Weidman, associate medical director for research at the Banner Alzheimer’s Institute, shares insights on Eli Lilly’s investigational Alzheimer’s…
In the past, scientists have overlooked the vascular system’s role in aging and dementia. But increasingly, research is showing that vascular dysfunction like damage…
Roughly one in 10 people worldwide, or over 700 million people, will experience hearing loss by 2050, and research suggests it is the leading…
Whether it’s forgetting a name or where we placed our keys and cell phone, memory lapses can be especially worrying for aging adults with…
For retired neurologist Daniel Gibbs, an Alzheimer’s diagnosis gave him not only a sense of relief, but a new lifestyle: one of healthier living,…
Retired neurologist Daniel Gibbs speaks about his own Alzheimer’s diagnosis, his unusual and severe case of side effects in aducanumab (Aduhelm) clinical trials, and…
Lifestyle changes can lower our dementia risk. Dr. Eric Larson, senior investigator at Kaiser Permanente Washington Health Research Institute, dives into the science to…
Cinical trial investigators for aducanumab (Aduhelm) discuss the significance of the drug’s recent FDA approval, the controversy surrounding its efficacy, and the uncertainty ahead….
As part of our LiveTalk series, Being Patient spoke with Dr. Jason Karlawish about the early diagnosis of Alzheimer’s and why it’s important for…
As part of our BrainTalk series, Being Patient spoke with Sandra Kooij about the symptoms and treatment options of ADHD for older adults and…
After the deaths of close family members and giving birth to her child, Kara Kirby began experiencing changes in her behavior and personality. Clinicians…
Biogen’s aducanumab — a human antibody-based drug that targets beta-amyloid plaques, which are found in the brains of people with Alzheimer’s — has gone…
As part of our BrainTalk series, newscaster Genevieve Glass speaks with Dr. Michael Geschwind about the causes of rapidly progressive dementias — relatively uncommon…